We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADTX
13276
PUT
DELISTED
ADITXT INC
ADTX
0
ANIX icon
13277
CALL
Anixa Biosciences
ANIX
$108M
$39K ﹤0.01%
+10,100
New +$43K
BRN icon
13278
Barnwell Industries
BRN
$13.9M
$39K ﹤0.01%
11,749
-22,953
-66% -$65.4K
CRVS icon
13279
CALL
Corvus Pharmaceuticals
CRVS
$1.25B
$39K ﹤0.01%
14,700
-10,700
-42% -$29.5K
SLACW
13280
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$39K ﹤0.01%
+35,400
New +$36K
STON
13281
PUT
DELISTED
StoneMor Inc.
STON
$39K ﹤0.01%
14,800
-95,900
-87% -$218K
GCACW
13282
DELISTED
Growth Capital Acquisition Corp. Warrant
GCACW
$39K ﹤0.01%
62,861
-197
-0.3% -$98
BDSI
13283
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$39K ﹤0.01%
10,800
-4,000
-27% -$14.1K
NMAD
13284
Nomad Power Solutions
NMAD
$74.1M
$38K ﹤0.01%
1,239
-1,142
-48% -$32.8K
RMTI icon
13285
CALL
Rockwell Medical
RMTI
$29.2M
$38K ﹤0.01%
380
-290
-43% -$29.9K
TGB
13286
CALL
Trekor Metals
TGB
$3.06B
$38K ﹤0.01%
18,000
-23,500
-57% -$50.5K
TTNP
13287
CALL
DELISTED
Titan Pharmaceuticals
TTNP
$38K ﹤0.01%
735
-545
-43% -$27.3K
VTGN icon
13288
VistaGen Therapeutics
VTGN
$11.9M
$38K ﹤0.01%
399
-3,208
-89% -$238K
YARW
13289
PUT
Yarrow Bioscience, Inc. Common Stock
YARW
$113M
$38K ﹤0.01%
+12
New +$47.5K
RNTX
13290
Rein Therapeutics
RNTX
$68.9M
$38K ﹤0.01%
1,511
-831
-35% -$20.7K
ZSAN
13291
DELISTED
Zosano Pharma Corporation
ZSAN
$38K ﹤0.01%
1,148
-3,444
-75% -$111K
NEW
13292
PUT
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$38K ﹤0.01%
+2,120
New +$58.4K
CNET icon
13293
PUT
ZW Data Action Technologies
CNET
$4.73M
$37K ﹤0.01%
915
-810
-47% -$31.2K
IBIO icon
13294
iBio
IBIO
$71M
$37K ﹤0.01%
49
-55
-53% -$40.1K
MSN icon
13295
Emerson Radio
MSN
$7.91M
$37K ﹤0.01%
31,411
-9,648
-23% -$11.5K
RCG
13296
RENN Fund
RCG
$19.4M
$37K ﹤0.01%
+15,471
New +$40.3K
TOUR
13297
CALL
Tuniu
TOUR
$53.2M
$37K ﹤0.01%
1,560
-1,260
-45% -$34.4K
VAL.WS icon
13298
Valaris Ltd Warrants
VAL.WS
$865M
$37K ﹤0.01%
+12,862
New +$27.8K
AMPE
13299
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$37K ﹤0.01%
74
-82
-53% -$44K
NEW
13300
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$37K ﹤0.01%
2,089
-4,543
-69% -$125K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.